Join this new InternKat on her first post to catch up on what you might have missed!
Eleonora Rosati reported on various upcoming events and conferences in Bergen, Santiago de Chile, and London. Also, don’t forget to check the news she reported if you are a copyright fan like this InternKat.
![]() |
Image by Riana Harvey |
Katfriends Sunimal Mendis and Olia Kanevskaia reported on the “Malamud” case (C-588/21 P Public.Resource.Org). Their post considers the copyrightability of harmonized technical standards (HTS), considering that HTS form part of EU law. One of the main issues in this dispute is finding a valid copyright claim to restrict public access to HTS.
Trade Marks
Katfriend Kimberley Evans discussed the refusal of the BASMATI trade mark registration in New Zealand. APEDA’s application to register the word BASMATI as a certification mark in that country was opposed due to lack of distinctiveness and insufficient certification rules. Even though the Assistant Commissioner listed the reasons for refusal in response to the reconsideration request, an appeal might occur, as well as possible future battles on GIs.
Patents and Designs
Jocelyn Bosse reviewed the book Terrell on the Law of Patents, which was first published in 1884 by Thomas Terrell. The latest volume provides a comprehensive look at the significant updates in UK patent law since the last edition in 2020. The book was edited and recently published by the skilled team of British IP Bar; Douglas Campbell KC taking over as general editor, and Tim Austen as deputy editor.
PatKat Rose Hughes analysed the T 0815/22 decision on the second medical use claim. The Board of Appeal was not convinced on several points; therefore, the patentee’s claims were found to lack novelty. It was acknowledged that prophylactic methods were considered as therapy, and the baby formula had therapeutic effects. However, the Board decided that providing a breastfeeding substitute cannot be regarded as therapeutic. According to the decision, the nutritional benefit is insufficient for additional IP protection for a second medical use patent.
Rose Hughes also reported on the decision Sanofi v Amgen, UPC_CFI_1/2023, focusing on the very first revocation before the UPC. This decision also highlights how the US and the UPC Central Division are strictly opposed to each other on the matter of antibody inventions.
Marcel Pemsel explored the recent case I-20 U 291/22 on the design for the housing of a car key. Volkswagen sued W+S for infringement of its registered Community design (‘RCD’). W+S appealed to the Higher Regional Court of Düsseldorf; however, RCD dismissed the appeal and counterclaim. This case opens the further discussion of all types of remote controls, going beyond car key housings.
![Never Too Late: If you missed the IPKat last week!](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjF_sJO_MdeyUSVhTxevbTnFSkGZAXlvVZ7PTRxytxKThhxcWQIH8SAUvLYd6MOUf_xeoNRN7xAQQd1-APjwqKmROjYYYsCtySYIwBIx1ku0b3-qPduaq1eWuIQdXUhxzw_eimYTZX_cY76H0HME3M_WYfpfs1dowBt7LMm-oa0RoU7k4upo_cvTw/s72-c/ipkat1.jpg)
No comments:
All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.
It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.
Learn more here: http://ipkitten.blogspot.com/p/want-to-complain.html